Elliana Kirsh DeVore, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Larynx | 3 | 2022 | 486 | 1.770 |
Why?
|
Vocal Cord Paralysis | 2 | 2022 | 265 | 1.220 |
Why?
|
Voice Quality | 3 | 2019 | 216 | 0.880 |
Why?
|
Vocal Cords | 4 | 2022 | 520 | 0.850 |
Why?
|
Voice Training | 1 | 2020 | 37 | 0.740 |
Why?
|
Stroboscopy | 2 | 2019 | 61 | 0.730 |
Why?
|
Sickness Impact Profile | 1 | 2019 | 305 | 0.630 |
Why?
|
Voice Disorders | 2 | 2019 | 275 | 0.600 |
Why?
|
Dysphonia | 1 | 2019 | 143 | 0.580 |
Why?
|
Laser Therapy | 1 | 2022 | 1065 | 0.530 |
Why?
|
Disability Evaluation | 2 | 2019 | 1824 | 0.520 |
Why?
|
Tonsillectomy | 2 | 2020 | 254 | 0.430 |
Why?
|
Insurance Coverage | 2 | 2020 | 1891 | 0.420 |
Why?
|
Postoperative Hemorrhage | 2 | 2020 | 410 | 0.400 |
Why?
|
Tonsillitis | 2 | 2020 | 30 | 0.390 |
Why?
|
Insurance, Health | 2 | 2020 | 2491 | 0.390 |
Why?
|
Deglutition Disorders | 2 | 2023 | 607 | 0.370 |
Why?
|
Adenoidectomy | 2 | 2020 | 159 | 0.350 |
Why?
|
Quality of Life | 3 | 2019 | 12640 | 0.340 |
Why?
|
Head and Neck Neoplasms | 3 | 2020 | 2706 | 0.320 |
Why?
|
Endolymphatic Sac | 1 | 2018 | 50 | 0.320 |
Why?
|
Palatine Tonsil | 1 | 2018 | 193 | 0.320 |
Why?
|
Ear Neoplasms | 1 | 2018 | 117 | 0.310 |
Why?
|
Systems Analysis | 1 | 2018 | 170 | 0.300 |
Why?
|
Deglutition | 1 | 2019 | 199 | 0.300 |
Why?
|
Meniere Disease | 1 | 2018 | 161 | 0.290 |
Why?
|
Health Status | 1 | 2019 | 4013 | 0.280 |
Why?
|
Jaundice, Chronic Idiopathic | 1 | 2022 | 3 | 0.220 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 767 | 0.210 |
Why?
|
Optical Fibers | 1 | 2022 | 138 | 0.210 |
Why?
|
Jaundice | 1 | 2022 | 89 | 0.210 |
Why?
|
Diverticulum | 1 | 2023 | 136 | 0.200 |
Why?
|
Ibuprofen | 1 | 2020 | 235 | 0.170 |
Why?
|
Leadership | 1 | 2018 | 1349 | 0.170 |
Why?
|
Esophageal pH Monitoring | 1 | 2019 | 187 | 0.160 |
Why?
|
Laryngectomy | 1 | 2020 | 244 | 0.160 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 130 | 0.150 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 232 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 365 | 0.150 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 244 | 0.150 |
Why?
|
Efficiency | 1 | 2020 | 461 | 0.150 |
Why?
|
Bronchoscopy | 1 | 2023 | 856 | 0.150 |
Why?
|
Pharynx | 1 | 2019 | 411 | 0.150 |
Why?
|
Patient Care Team | 1 | 2018 | 2527 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 395 | 0.140 |
Why?
|
Laryngoscopy | 2 | 2019 | 703 | 0.140 |
Why?
|
ROC Curve | 2 | 2023 | 3526 | 0.130 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2558 | 0.130 |
Why?
|
Glottis | 1 | 2016 | 216 | 0.120 |
Why?
|
Face | 1 | 2020 | 985 | 0.120 |
Why?
|
Phonation | 1 | 2016 | 219 | 0.120 |
Why?
|
Occupations | 1 | 2016 | 517 | 0.110 |
Why?
|
Otolaryngology | 1 | 2020 | 644 | 0.110 |
Why?
|
Endoscopy | 1 | 2022 | 1762 | 0.110 |
Why?
|
Income | 1 | 2020 | 1877 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15511 | 0.100 |
Why?
|
Humans | 21 | 2023 | 739398 | 0.100 |
Why?
|
Adult | 10 | 2022 | 213394 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1638 | 0.090 |
Why?
|
Male | 14 | 2022 | 349022 | 0.090 |
Why?
|
Audiometry | 1 | 2018 | 241 | 0.080 |
Why?
|
Adolescent | 5 | 2020 | 85405 | 0.080 |
Why?
|
Female | 11 | 2020 | 378853 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57650 | 0.080 |
Why?
|
Middle Aged | 7 | 2020 | 212863 | 0.070 |
Why?
|
Risk Assessment | 1 | 2018 | 23294 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2022 | 76631 | 0.070 |
Why?
|
Prospective Studies | 3 | 2019 | 53037 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 24714 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10362 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4014 | 0.060 |
Why?
|
Temporal Bone | 1 | 2018 | 663 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 38942 | 0.060 |
Why?
|
Aged | 5 | 2020 | 162698 | 0.060 |
Why?
|
Young Adult | 4 | 2019 | 56255 | 0.060 |
Why?
|
Medicare | 1 | 2020 | 6497 | 0.050 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 802 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2872 | 0.050 |
Why?
|
United States | 4 | 2020 | 69573 | 0.050 |
Why?
|
Child | 4 | 2020 | 77033 | 0.050 |
Why?
|
Feminization | 1 | 2020 | 21 | 0.050 |
Why?
|
Liver Function Tests | 1 | 2022 | 527 | 0.050 |
Why?
|
Bilirubin | 1 | 2022 | 415 | 0.050 |
Why?
|
Personal Satisfaction | 1 | 2013 | 629 | 0.040 |
Why?
|
Social Environment | 1 | 2013 | 1014 | 0.040 |
Why?
|
Patient Advocacy | 1 | 2020 | 353 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15194 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19811 | 0.040 |
Why?
|
Transsexualism | 1 | 2020 | 173 | 0.040 |
Why?
|
Incidence | 2 | 2020 | 20913 | 0.040 |
Why?
|
Loudness Perception | 1 | 2016 | 24 | 0.040 |
Why?
|
Pitch Perception | 1 | 2016 | 114 | 0.030 |
Why?
|
Acoustics | 1 | 2016 | 240 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2020 | 1296 | 0.030 |
Why?
|
Vibration | 1 | 2016 | 326 | 0.030 |
Why?
|
Judgment | 1 | 2016 | 282 | 0.030 |
Why?
|
Infant | 2 | 2020 | 34923 | 0.030 |
Why?
|
Quality Improvement | 1 | 2018 | 3730 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12948 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 71974 | 0.030 |
Why?
|
Child, Preschool | 2 | 2020 | 40802 | 0.030 |
Why?
|
Pressure | 1 | 2016 | 1201 | 0.030 |
Why?
|
Video Recording | 1 | 2016 | 936 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2655 | 0.020 |
Why?
|
Visual Perception | 1 | 2016 | 1418 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10398 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13635 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20055 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2020 | 21694 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35326 | 0.010 |
Why?
|